Differential effect of retinoic acid on growth regulation by phorbol ester in human cancer cell lines

被引:38
作者
Agadir, A
Chen, GQ
Bost, F
Li, Y
Mercola, D
Zhang, XK
机构
[1] Burnham Inst, Canc Res Ctr, La Jolla, CA 92037 USA
[2] Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA
关键词
D O I
10.1074/jbc.274.42.29779
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) and all-trans-retinoic acid (trans-RA) are potent regulators of growth of cancer cells. In this study, we investigated the effect of TPA and trans-RA alone or their combination on proliferation of human breast cancer ZR75-1 and T47D and lung cancer H460 and H292 cell lines. trans-RA caused various degrees of growth inhibition of these cell lines. However, TPA showed inhibition of proliferation of H460 and H292 cells and induction of ZR75-1 cell growth. Although trans-RA did not significantly regulate the growth inhibitory effect of TPA, it completely prevented its growth stimulating function. The divergent effects of TPA were associated with specific disruption of cell cycle events, an induction of G(0)/G(1) arrest in H460 and H292 cells and inhibition of G(0)/G(1) arrest with increase of S phase in ZR75-1 cells. Induction of G(0)/G(1) arrest was accompanied by induction of p21(WAF1) and ERK activity, whereas inhibition of G(0)/G(1) arrest was associated with enhanced activity of JNK and AP-1 but not ERK. trans-RA did not affect TPA-induced p21(WAF1) expression. However, it inhibited TPA-induced AP-1 activity in ZR75-1 cells and the constitutive AP-1 activity in H460 and H292 cells, Thus, trans-RA modulates TPA activity through its interaction through TPA-induced JNK/AP-1 pathway but not TPA-induced ERK/p21(WAF1) pathway.
引用
收藏
页码:29779 / 29785
页数:7
相关论文
共 48 条
[1]  
Agadir A, 1997, CANCER RES, V57, P3444
[2]   THE ROLE OF JUN, FOS AND THE AP-1 COMPLEX IN CELL-PROLIFERATION AND TRANSFORMATION [J].
ANGEL, P ;
KARIN, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1072 (2-3) :129-157
[3]  
ARITA Y, 1992, CANCER RES, V52, P4514
[4]   REGULATION OF PROTEIN-KINASE-C AND ROLE IN CANCER BIOLOGY [J].
BLOBE, GC ;
OBEID, LM ;
HANNUN, YA .
CANCER AND METASTASIS REVIEWS, 1994, 13 (3-4) :411-431
[5]   Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway [J].
Caelles, C ;
González-Sancho, JM ;
Muñoz, A .
GENES & DEVELOPMENT, 1997, 11 (24) :3351-3364
[6]  
COLLINS SJ, 1987, BLOOD, V70, P1233
[7]   INHIBITION OF THE MELANOMA CELL-CYCLE AND REGULATION AT THE G1/S TRANSITION BY 12-O-TETRADECANOYLPHORBOL-13-ACETATE (TPA) BY MODULATION OF CDK2 ACTIVITY [J].
COPPOCK, DL ;
BUFFOLINO, P ;
KOPMAN, C ;
NATHANSON, L .
EXPERIMENTAL CELL RESEARCH, 1995, 221 (01) :92-102
[8]   PROTEIN-KINASE-C - A QUESTION OF SPECIFICITY [J].
DEKKER, LV ;
PARKER, PJ .
TRENDS IN BIOCHEMICAL SCIENCES, 1994, 19 (02) :73-77
[9]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[10]   Redox-mediated regulation of p21(waf1/cip1) expression involves a post-transcriptional mechanism and activation of the mitogen-activated protein kinase pathway [J].
Esposito, F ;
Cuccovillo, F ;
Vanoni, M ;
Cimino, F ;
Anderson, CW ;
Appella, E ;
Russo, T .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 245 (03) :730-737